1. Market Research
  2. > Pharmaceutical Market Trends
  3. > Drug Discovery and Development

Drug Discovery & Development Sector: Latest Market Trends and Statistics

  • Currently 3/5 Stars.
  • 1
  • 2
  • 3
  • 4
  • 5
13 votes

Global Drug Discovery and Development Industry

The global drug discovery and development industry (part of the wider pharmaceutical industry) involves the discovery and design of drugs through laboratory testing to treat disease and infection. With costs running high and few drugs making it to the market, drug discovery and development leaders are constantly seeking ways to reduce expenditure and boost efficiency.

One option companies frequently avail of is the practice of outsourcing sections of the discovery and development process. The global drug discovery outsourcing market is expected to grow from less than $7.5 billion in 2009 to a forecast worth of $18.5 billion in 2015, according to Business Insights. Meanwhile, the global drug discovery technologies market is expected to be worth more than $32 billion by 2012, growing at an annual compound rate in excess of 8%.

The industry requires heavy investment with no guarantee of results, including under 1% of discoveries going on to be approved by the US Food and Drug Administration. The process itself can take between 12 and 20 years, and cost over the $1.2 billion mark, reports the Alfred Mann Foundation for Biomedical Engineering.

Leading Market Segments

It is estimated that high throughput screening will be worth $12 billion by 2012, showing over 7% growth in the preceding five years.

Bioanalytical instruments have a forecast worth of $10.5 billion in 2012, demonstrating growth in excess of 9%. It is believed the segment of other technologies should come close to the $4.5 billion mark in 2012. Business Insights estimates the electronic data capture market for clinical trials will pass the $1 billion mark in 2016 at 13% annual growth.

Process: Drug Testing and Development

The steps involved in drug discovery begin with the identification of targets, which are genetic or cellular chemicals that influence disease. Once the target has been isolated, the compounds that may work best on them can in turn be determined. Next, the chosen target’s capacity to act on diseased cells is observed before compounds necessary to create a drug are determined, along with the drug target’s response to the compound. In the next phase compounds are compared and data is compiled to aid biopharmaceutical companies to determine the most promising compound for drug creation.

Once a drug has been designed, it enters the preclinical phase of development in which it is tested for up to five years to establish its impact on cells. The drug also undergoes toxicology testing to determine any possible harm to humans. In the clinical phase, drugs are administered to humans to test efficacy and potential side effects before companies seek authorization to market the new drug. Research compiled throughout the process is submitted to the relevant authority as the company awaits approval; this part of the process can last up to two years.

Contract Research Organization (CRO) Market Value (2005 - 2010) 

Read more »

24/7 Customer Support

Talk to Sam

+44 20 8816 8032

1-10 of about 300 reports

Global Drug Discovery And Development Industry Forecast

  • January 2016
    10 pages
  • Drug Discovery  

  • World  

View report >

Drug Discovery And Development Industry in the US Forecast

  • January 2015
    17 pages
  • Drug Discovery  

  • United States  

View report >

Drug Discovery And Development Industry in Europe Forecast

  • December 2015
    5 pages
  • Drug Discovery  

  • Europe  


View report >

Drug Discovery And Development Industry in Japan

  • March 2016
    18 pages
  • Drug Discovery  

  • Japan  



View report >

Clinical Research Market Demand in the US

  • April 2016
    2 pages
  • Clinical Resear  

  • United States  

    North America  

View report >

Pathology Description in Australia

  • March 2016
    8 pages
  • Cancer  

    Clinical Trial  

  • Australia  

View report >

Clinical Research Industry in the UK

  • March 2016
    4 pages
  • Clinical Resear  

  • United Kingdom  

View report >

Search in Drug Discovery And Development Industry (About 300 reports)
Parent industry: Pharmaceutical
Related industries: Drug Delivery Technology, Drug and Medication, Generic Drug, Over-The-Counter Drug, Pharmacies and Drug Stores, Prescription Drug, Pathology, Therapy, Vitamin and Supplement

About 2 100 reports

Purchase Reports From Reputable Market Research Publishers
(From € 100 - € 5 320)

Genome Editing: Technologies and Global Markets

Genome Editing: Technologies and Global Markets

  • € 5 320
  • Industry report
  • March 2016
  • by BCC Research

This BCC Research report provides detailed market and industry analyses of the rapidly growing global market for genome editing. Important trends of the field and market segments are identified, and market ...

Global Viral Infections Market To 2021 - Promising New ...

April 2016 € 3 996

Global Non-hematological Cancers Market To 2021 - Stron ...

April 2016 € 3 996

Asthma Therapeutics In Asia-pacific Markets To 2021 - H ...

March 2016 € 3 996

Alzheimer’s Therapeutics In Asia-pacific Markets To 2 ...

March 2016 € 3 996

Drug Discovery Informatics - Global Market Outlook (201 ...

March 2016 € 3 922

Pharmacovigilance Market Analysis By Clinical Trial Pha ...

May 2016 € 3 760

Bioinformatics Market Analysis And Segment Forecasts To ...

May 2016 € 3 760

Biochips Market By Type Lab-on-a-chip, Protein Chips, E ...

May 2016 € 3 720

North American Nuclear Medicine/radiopharmaceuticals Ma ...

March 2016 € 3 720

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.